Show simple item record

dc.contributor.authorDoherty, Garyen
dc.contributor.authorKerr, Emma Men
dc.contributor.authorPedro Martins, Carlaen
dc.date.accessioned2018-03-29T13:07:14Z
dc.date.available2018-03-29T13:07:14Z
dc.date.issued2017-05en
dc.identifier.issn1471-4914
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/274499
dc.format.mediumPrint-Electronicen
dc.languageengen
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectHumansen
dc.subjectLeukemiaen
dc.subjectBenzamidesen
dc.subjectDiphenylamineen
dc.subjectMAP Kinase Kinase 1en
dc.subjectMAP Kinase Kinase 2en
dc.subjectGene Dosageen
dc.subjectAllelic Imbalanceen
dc.subjectModels, Theoreticalen
dc.subjectProto-Oncogene Proteins p21(ras)en
dc.titleKRAS Allelic Imbalance: Strengths and Weaknesses in Numbers.en
dc.typeArticle
prism.endingPage378
prism.issueIdentifier5en
prism.publicationDate2017en
prism.publicationNameTrends in molecular medicineen
prism.startingPage377
prism.volume23en
dc.identifier.doi10.17863/CAM.21617
dcterms.dateAccepted2017-03-20en
rioxxterms.versionofrecord10.1016/j.molmed.2017.03.005en
rioxxterms.versionAM*
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2017-05en
dc.contributor.orcidDoherty, Gary Joseph [0000-0002-8158-8111]
dc.identifier.eissn1471-499X
rioxxterms.typeJournal Article/Reviewen
pubs.funder-project-idMRC (MC_UU_12022/1_do not transfer?)
pubs.funder-project-idMedical Research Council (MC_UU_12022/4)
rioxxterms.freetoread.startdate2018-03-31


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's licence is described as Attribution-NonCommercial-NoDerivatives 4.0 International